Cargando…

Reactivation of latent HIV-1 in central memory CD4(+) T cells through TLR-1/2 stimulation

BACKGROUND: Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system. TLRs are present and functional in CD4(+) T cells. Memory CD4(+) T cells, predominantly central memory cells (T(CM)), constitute the main reservoir of la...

Descripción completa

Detalles Bibliográficos
Autores principales: Novis, Camille L, Archin, Nancie M, Buzon, Maria J, Verdin, Eric, Round, June L, Lichterfeld, Mathias, Margolis, David M, Planelles, Vicente, Bosque, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826617/
https://www.ncbi.nlm.nih.gov/pubmed/24156240
http://dx.doi.org/10.1186/1742-4690-10-119
Descripción
Sumario:BACKGROUND: Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system. TLRs are present and functional in CD4(+) T cells. Memory CD4(+) T cells, predominantly central memory cells (T(CM)), constitute the main reservoir of latent HIV-1. However, how TLR ligands affect the quiescence of latent HIV within central memory CD4(+) T cells has not been studied. RESULTS: We evaluated the ability of a broad panel of TLR agonists to reactivate latent HIV-1. The TLR-1/2 agonist Pam3CSK4 leads to viral reactivation of quiescent HIV in a model of latency based on cultured T(CM) and in resting CD4(+) T cells isolated from aviremic patients. In addition, we investigated the signaling pathway associated with Pam3CSK4 involved in HIV-1 reactivation. We show that the transcription factors NFκB, NFAT and AP-1 cooperate to induce viral reactivation downstream of TLR-1/2 stimulation. Furthermore, increasing levels of cyclin T1 is not required for TLR-mediated viral reactivation, but induction of viral expression requires activated pTEFb. Finally, Pam3CSK4 reactivates latent HIV-1 in the absence of T cell activation or proliferation, in contrast to antigen stimulation. CONCLUSIONS: Our findings suggest that the signaling through TLR-1/2 pathway via Pam3CSK4 or other reagents should be explored as an anti-latency strategy either alone or in combination with other anti-latency drugs.